120 related articles for article (PubMed ID: 30516671)
1. Increased 99mTc Pertechnetate Uptake But Unimpressive 131I Activity in the Metastatic Mediastinal Lymph Nodes in a Thyroid Cancer Patient.
Shao F; Zhou D; Lan X
Clin Nucl Med; 2019 Feb; 44(2):176-178. PubMed ID: 30516671
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-pertechnetate whole-body SPET/CT scan in thyroidectomized differentiated thyroid cancer patients is a useful imaging modality in detecting remnant thyroid tissue, nodal and distant metastases before
Lou K; Gu Y; Hu Y; Wang S; Shi H
Hell J Nucl Med; 2018; 21(2):121-124. PubMed ID: 30089313
[TBL] [Abstract][Full Text] [Related]
3. Selectively false-positive radionuclide scan in a patient with sarcoidosis and papillary thyroid cancer: a case report and review of the literature.
Lebo NL; Raymond F; Odell MJ
J Otolaryngol Head Neck Surg; 2015 May; 44(1):18. PubMed ID: 25971453
[TBL] [Abstract][Full Text] [Related]
4. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
5. Comparison of post-therapeutic sequential 131I whole-body scans in the detection of metastatic thyroid cancer.
Qiu L; Tan H; Yin H; Zhou J; Cheng D; Shi H
Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):313-320. PubMed ID: 30221907
[TBL] [Abstract][Full Text] [Related]
6. Negative remnant
Lan W; Gege Z; Ningning L; Qiang W; Lin B; Qingjie M; Bin J
Ann Nucl Med; 2019 Feb; 33(2):112-118. PubMed ID: 30374858
[TBL] [Abstract][Full Text] [Related]
7. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
Scott GC; Meier DA; Dickinson CZ
J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053
[TBL] [Abstract][Full Text] [Related]
8. Preoperative scintigraphic visualization of lymph nodes and pulmonary metastases from papillary thyroid carcinoma.
Boughattas S; Hassine H; Arifa N; Chatti K; Degdegui M; Abdelkefi M; Essabbah H
Ann Nucl Med; 2004 Feb; 18(1):59-62. PubMed ID: 15072185
[TBL] [Abstract][Full Text] [Related]
9. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of iodine-131 and technetium-99m pertechnetate in thyroid carcinoma.
Katagiri M; Suzuki S; Sadahiro S; Kubouchi K; Ohmura T; Tsumura O; Akatsuka S
Clin Nucl Med; 1988 Apr; 13(4):276-9. PubMed ID: 2836118
[TBL] [Abstract][Full Text] [Related]
11. Visualization of papillary thyroid carcinoma and its metastatic lymph nodes. Images with Tc-99m pertechnetate, Tl-201, and Tc-99m sestamibi.
Alper E; Akbunar T; Tamgac F
Clin Nucl Med; 1996 Oct; 21(10):815-6. PubMed ID: 8896938
[No Abstract] [Full Text] [Related]
12. Accumulation of technetium-99m pertechnetate in a patient with metastases of thyroid carcinoma.
Yamamoto Y; Nishiyama Y; Ono Y; Satoh K; Ohkawa M; Kawasaki Y; Tanabe M
Ann Nucl Med; 1999 Oct; 13(5):357-9. PubMed ID: 10582808
[TBL] [Abstract][Full Text] [Related]
13. Clinical approach in patients with metastatic differentiated thyroid carcinoma and negative 131I whole body scintigraphy: importance of 99mTc MIBI scan combined with high resolution neck ultrasonography.
Casara D; Rubello D; Saladini G; Mazzarotto R; Sotti G; Tomasella G; Pelizzo MR
Tumori; 1999; 85(2):122-7. PubMed ID: 10363078
[TBL] [Abstract][Full Text] [Related]
14. Insensitivity of Tc-99m pertechnetate for detecting metastases of differentiated thyroid carcinoma.
Campbell CM; Khafagi FA
Clin Nucl Med; 1990 Jan; 15(1):1-4. PubMed ID: 2155079
[TBL] [Abstract][Full Text] [Related]
15. The use of technetium-99m pertechnetate in postoperative thyroid carcinoma. A comparative study with iodine-131.
Khammash NF; Halkar RK; Abdel-Dayem HM
Clin Nucl Med; 1988 Jan; 13(1):17-22. PubMed ID: 2832116
[TBL] [Abstract][Full Text] [Related]
16. Focal thoracic uptake mimicking lung metastasis on 131I post-therapy whole-body scan in patients with thyroid carcinoma.
Jia C; Moadel R; Freeman LM
Clin Nucl Med; 2014 Apr; 39(4):360-2. PubMed ID: 24598344
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of (99m)Tc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients.
Chantadisai M; Kingpetch K
Ann Nucl Med; 2014 Aug; 28(7):674-82. PubMed ID: 24889127
[TBL] [Abstract][Full Text] [Related]
18. 99mTc pertechnetate thyroid scan leads to serendipitous detection of metastatic thyroid cancer.
Mathiopoulou L; Chrisoulidou A; Boudina M; Mitsakis P; Mandanas S; Pazaitou-Panayiotou K
Clin Nucl Med; 2012 Jun; 37(6):604-6. PubMed ID: 22614199
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from 131I therapy: A prospective observational study.
Liu M; Chai L; Luo Q; Ruan M; Cheng L; Lv Z; Chen L
Medicine (Baltimore); 2017 Aug; 96(33):e7631. PubMed ID: 28816945
[TBL] [Abstract][Full Text] [Related]
20. Metastatic thyroid cancer visualized on technetium pertechnetate and iodine-131 scintigraphy.
Verma N; Singh-Wadhwa S; Arvela OM
Clin Nucl Med; 2002 Aug; 27(8):610. PubMed ID: 12170017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
